SCHEMBL28496187

SCHEMBL28496187

O=C(OC1CCNCC1)c1cnccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ NAPRT Q6XQN6 1/20 0.44
▸ HCAR2 Q8TDS4 1/20 0.44
▸ POLB P06746 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.43
▸ MC4R P32245 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ MC3R P41968 1/20 0.43
▸ UTS2R Q9UKP6 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.41
▸ MKNK2 Q9HBH9 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ SMYD3 Q9H7B4 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ P2RY14 Q15391 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15012541 0.84 TSHR (0.57) TSHRKDM4ENAPRTHCAR2ADORA3
SCHEMBL23407905 0.81 CES2 (0.46) KDM4ENAPRTUTS2RCHRNB2CHRNA4
SCHEMBL23418669 0.79 ALDH1A1 (0.51) HCAR2MKNK1MKNK2CHRNB2CHRNA4
SCHEMBL28184168 0.77 KDM4E (0.42) KDM4EUTS2R
SCHEMBL23407891 0.75 TMEM97 (0.41) KDM4EPOLBKMT2A
SCHEMBL13531267 0.74 NPC1 (0.42) TSHRHCAR2MAPTCYP1A2KMT2A
SCHEMBL29771778 0.73 CHRNB2 (0.46) NAPRTUTS2RMKNK1MKNK2CHRNB2
SCHEMBL9563007 0.72 TSHR (0.61) TSHRKDM4ENAPRTHCAR2POLB
SCHEMBL875263 0.72 KDM4E (0.61) TSHRKDM4ENAPRTHCAR2POLB
SCHEMBL29556324 0.72 KDM4E (0.61) TSHRKDM4ENAPRTHCAR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112079769-A Carboxamide compounds for the treatment of metabolic disorders 里格尔药品股份有限公司 2020-12-15 — — CN disclosed
CN-106928211-B Carboxamide compounds for the treatment of metabolic disorders 里格尔药品股份有限公司 2020-09-08 — — CN disclosed
Send feedback